Real-time enrollment status for this esophageal cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:01 AM UTC
| NCT Number | NCT05319730 |
| Recruiting Status | Recruiting |
| Condition | Esophageal Cancer |
| Phase | PHASE1 |
| Target Enrollment | 230 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT05319730 is currently recruiting participants. This phase1 study for esophageal cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05319730 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05319730 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.